Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2015 · 10-Q
Revenue—
Net Income$76.00K$76.00K+18.8% vs Q1 2014 EPS Diluted$0.00$0.00— vs Q1 2014 Operating Income$75,000+19.0% Operating Cash Flow$89,000+229.6%
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 12, 2015 · 42 d after period end